Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fatty acids and beyond: Age and Alzheimer's disease related changes in lipids reveal the neuro-nutraceutical potential of lipids in cognition
Kei-Lin Murata Ooi, Kristina Vacy, Wah Chin Boon
Neurochemistry International (2021) Vol. 149, pp. 105143-105143
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Oxidative stress: The nexus of obesity and cognitive dysfunction in diabetes
Huimin Li, Jing Ren, Yusi Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 55
Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics
Yaxi Luo, Ling-Ling Yang, Xiu‐Qing Yao
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 13
Cord blood lipid correlation network profiles are associated with subsequent attention-deficit/hyperactivity disorder and autism spectrum disorder symptoms at 2 years: a prospective birth cohort study
Kristina Vacy, Sarah Thomson, Archer Moore, et al.
EBioMedicine (2024) Vol. 100, pp. 104949-104949
Open Access | Times Cited: 10
Cortical lipid metabolic pathway alteration of early Alzheimer’s disease and candidate drugs screen
Linshuang Wang, Fengxue Qu, Xueyun Yu, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 6
Danggui-Shaoyao-San Attenuates Cognitive Impairment via the Microbiota–Gut–Brain Axis With Regulation of Lipid Metabolism in Scopolamine-Induced Amnesia
Piaoxue Liu, Xun Zhou, Haoran Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
In vivo neuroprotective capacity of a Dunaliella salina extract - comprehensive transcriptomics and metabolomics study
Alberto Valdés, José David Sánchez-Martínez, Rocío Gallego, et al.
npj Science of Food (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 5
Aging, sex, metabolic and life experience factors: Contributions to neuro-inflammaging in Alzheimer’s disease research
Pasindu Hansana Singhaarachchi, Péter Antal, Frédéric Calon, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 162, pp. 105724-105724
Open Access | Times Cited: 5
Status of Metabolomic Measurement for Insights in Alzheimer’s Disease Progression—What Is Missing?
Chunyuan Yin, Amy C. Harms, Thomas Hankemeier, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4960-4960
Open Access | Times Cited: 12
Assessing the causal role of lipid metabolites in Alzheimer's disease: A mendelian randomization study
Haoxiang Hu, Jiesheng Mao, Yunhan Zhao, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100067-100067
Open Access
The major anthocyanin of Lycium ruthenicum Murr. relieves cognitive deficits, oxidative stress, neuroinflammation, and hippocampal metabolome alterations in aging rats
Shasha Chen, Na Hu, Honglun Wang, et al.
Journal of Functional Foods (2022) Vol. 94, pp. 105104-105104
Open Access | Times Cited: 16
Diabetes Mellitus and Energy Dysmetabolism in Alzheimer’s Disease: Understanding the Relationships and Potential Therapeutic Targets
Adejoke Y. Onaolapo, Folusho O. Ojo, Olufunto O. Adeleye, et al.
Current Diabetes Reviews (2023) Vol. 19, Iss. 8
Closed Access | Times Cited: 9
Metabolic profiling of Alzheimer's disease: Untargeted metabolomics analysis of plasma samples
Tina Milos, David Rojo, Gordana Nedić Erjavec, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 127, pp. 110830-110830
Closed Access | Times Cited: 9
Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages
Carmen Peña‐Bautista, Lourdes Álvarez‐Sánchez, Antonio José Cañada Martínez, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1812-1812
Open Access | Times Cited: 22
Fecal 16S rRNA sequencing and multi-compartment metabolomics revealed gut microbiota and metabolites interactions in APP/PS1 mice
Xin Cheng, Yejun Tan, Hongli Li, et al.
Computers in Biology and Medicine (2022) Vol. 151, pp. 106312-106312
Closed Access | Times Cited: 15
Synergistic effects of tilapia head protein hydrolysate and walnut protein hydrolysate on the amelioration of cognitive impairment in mice
Jun Ji, Xiangzhou Yi, Xia Gao, et al.
Journal of the Science of Food and Agriculture (2024) Vol. 104, Iss. 9, pp. 5419-5434
Closed Access | Times Cited: 2
Six genetically linked mutations in the CD36 gene significantly delay the onset of Alzheimer's disease
Omar Šerý, Tomáš Zeman, Kateřina Sheardová, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Sex differences in plasma lipid profiles of accelerated brain aging
Qu Tian, Brendan A. Mitchell, Güray Erus, et al.
Neurobiology of Aging (2023) Vol. 129, pp. 178-184
Open Access | Times Cited: 6
Fundamental neurochemistry review: Old brain stories ‐ Influence of age and sex on the neurodegeneration‐associated lipid changes
Lorena Cuenca‐Bermejo, Alessandro Prinetti, Karolina Kublickiene, et al.
Journal of Neurochemistry (2023) Vol. 166, Iss. 3, pp. 427-452
Open Access | Times Cited: 5
How can early stress influence later Alzheimer risk? Possible mediators and underlying mechanisms.
Paul J. Lucassen, Anikó Kőrösi, Susanne R. de Rooij, et al.
Biological Psychiatry (2024)
Open Access | Times Cited: 1
Synthesis, characterization, DFT and molecular docking studies of acetone O-((2,5-dichlorophenyl)sulfonyl) oxime
Adem Korkmaz, Lydia Rhyman, Ponnadurai Ramasami
Physical Sciences Reviews (2022) Vol. 8, Iss. 11, pp. 4017-4028
Closed Access | Times Cited: 7
Neuro-nutraceuticals: Natural products nourish the brain but be aware of contrary effects
Robert J. Williams, Kochupurackal P. Mohanakumar, Philip M. Beart
Neurochemistry International (2021) Vol. 150, pp. 105159-105159
Closed Access | Times Cited: 8
Developmental brain lipidomics is influenced by postnatal chlorpyrifos exposure and APOE genetic background in mice
Laia Guardia-Escote, Judit Biosca-Brull, María Cabré, et al.
Archives of Toxicology (2023) Vol. 97, Iss. 9, pp. 2463-2475
Open Access | Times Cited: 2
Host response to Aplysia Abyssovirus 1 in nervous system and gill
Nicholas S. Kron, Lynne A. Fieber, L. Baker, et al.
Developmental & Comparative Immunology (2024) Vol. 159, pp. 105211-105211
Closed Access
Gut microbiome synthesizes important core metabolites to prevent cognitive decline and mitigate onset and progression of Alzheimer's disease
Nouf S. Al-Abbas, Nehad A. Shaer
Journal of Alzheimer s Disease Reports (2024) Vol. 8, Iss. 1, pp. 1705-1721
Open Access
Exploring the potential of neuronutraceuticals as alternatives in the prevention of Alzheimer’s disease
Ankur Kumar, Rouchan Ali, Ram Kumar, et al.
Pharmaspire (2022) Vol. 14, Iss. 01, pp. 47-58
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top